BOLDEUR
Audentes Therapeutics Inc
Early-stage biotechnology company developing gene therapies for rare life-threatening genetic diseases
CUSIP: 05070R104HealthcareUS1 holder
Total Value
$816.0K
Total Shares
45.8K
Net Share Change
+45.8K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Leon Cooperman
$816.0K45.8K sharesNEW